Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ros Eeles

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Cancers|July 13, 2024
Online Provision of <i>BRCA1</i> and <i>BRCA2</i> Health Information: A Search Engine Driven Systematic Web-Based AnalysisTamar A Gootzen, Ashwin Kalra, Katrina Sarig, et al.
Hereditary Cancer in Clinical Practice|November 25, 2011
Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening testsMarielle Ae Nobbenhuis, Elizabeth Bancroft, Eleanor Moskovic, et al.
British Journal of Cancer|April 13, 2016
Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicityMahbubl Ahmed, Leila Dorling, Sarah Kerns, et al.
Cancer Research|February 3, 2006
Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriersGillian Mitchell, Antonis C Antoniou, Ruth Warren, et al.
Nature Cancer|July 12, 2024
Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancerJavier Fernandez-Mateos, George D Cresswell, Nicholas Trahearn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 6, 2015
A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal CancerPeter M Scarbrough, Rachel Palmieri Weber, Edwin S Iversen, et al.
The Lancet. Oncology|January 17, 2018
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort studyEllen R Copson, Tom C Maishman, Will J Tapper, et al.
BJC Reports|November 8, 2024
Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genesSarah Benafif, Ann-Britt Jones, Susan Merson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 23, 2018
Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE studyFabio Girardi, Daniel R Barnes, Daniel Barrowdale, et al.
Breast Cancer Research : BCR|April 20, 2012
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriersAna-Teresa Maia, Antonis C Antoniou, Martin O'Reilly, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Cancers|July 13, 2024
Online Provision of <i>BRCA1</i> and <i>BRCA2</i> Health Information: A Search Engine Driven Systematic Web-Based AnalysisTamar A Gootzen, Ashwin Kalra, Katrina Sarig, et al.
Hereditary Cancer in Clinical Practice|November 25, 2011
Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening testsMarielle Ae Nobbenhuis, Elizabeth Bancroft, Eleanor Moskovic, et al.
British Journal of Cancer|April 13, 2016
Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicityMahbubl Ahmed, Leila Dorling, Sarah Kerns, et al.
Cancer Research|February 3, 2006
Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriersGillian Mitchell, Antonis C Antoniou, Ruth Warren, et al.
Nature Cancer|July 12, 2024
Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancerJavier Fernandez-Mateos, George D Cresswell, Nicholas Trahearn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 6, 2015
A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal CancerPeter M Scarbrough, Rachel Palmieri Weber, Edwin S Iversen, et al.
The Lancet. Oncology|January 17, 2018
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort studyEllen R Copson, Tom C Maishman, Will J Tapper, et al.
BJC Reports|November 8, 2024
Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genesSarah Benafif, Ann-Britt Jones, Susan Merson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 23, 2018
Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE studyFabio Girardi, Daniel R Barnes, Daniel Barrowdale, et al.
Breast Cancer Research : BCR|April 20, 2012
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriersAna-Teresa Maia, Antonis C Antoniou, Martin O'Reilly, et al.
Pageof 8